CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Genomic Sequencinggenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04196374
NCT04196374N/ACompleted

Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts

Brigham and Women's Hospital·interventional·Posted Dec 12, 2019·Updated Nov 12, 2025

In Brief

A clinical study evaluating Genomic Sequencing for Seemingly Healthy and Genetic Predisposition to Disease. Completed, enrolled 48 participants across 2 sites.

Detailed Summary

The PopSeq Project is a prospective cohort study that will develop and implement a genomic return of results (gRoR) process in the Framingham Heart Study (FHS) and Jackson Heart Study (JHS) cohorts and explore associated medical, behavioral, and economic outcomes. The study will interpret the genomic sequences of JHS/FHS participants previously sequenced by TOPMed who have consented to genomic return of results and/or genetic testing. We will develop and apply new methods for scalable screening/ classification of genomic variants and will explore genomic penetrance by phenotyping a subset of participants in the FHS and JHS.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 12, 2019
Enrollment StartJun 9, 2021
Primary CompletionMay 30, 2025
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 6.6 years ago

Interventions

Genomic Sequencinggenetic

Whole Genome Sequencing and reporting of actionable genomic results for genes included on the ACMG secondary findings list.